The TechCrunch Live Podcast helps founders build better venture backed businesses. Each week, we chat with experienced entrepreneurs and investors on their past wins and losses — particularly the pitches that helped build the business at an early stage.
All content for The TechCrunch Live Podcast is the property of TechCrunch and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The TechCrunch Live Podcast helps founders build better venture backed businesses. Each week, we chat with experienced entrepreneurs and investors on their past wins and losses — particularly the pitches that helped build the business at an early stage.
How Cambrian BioPharma is reinventing drug - and drug company - development
The TechCrunch Live Podcast
56 minutes 35 seconds
2 years ago
How Cambrian BioPharma is reinventing drug - and drug company - development
We're talking about developing therapeutics for anti-aging. Matt Burns interviewed James Peyer, the co-founder of Cambrian BioPharma, and Maryanna Saenko, co-founder and partner at Future Ventures. Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development and raised over $180 million to accelerate the development of medicine designed to target the causes of age-related diseases.
The TechCrunch Live Podcast
The TechCrunch Live Podcast helps founders build better venture backed businesses. Each week, we chat with experienced entrepreneurs and investors on their past wins and losses — particularly the pitches that helped build the business at an early stage.
